ORJ-001
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Oorja Bio, Inc.
Overview
ORJ-001 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
ORJ-001 clinical trials
Explore related
Medical disclaimer. This page summarizes research about ORJ-001 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.